IP6K2 mutations as a novel mechanism of resistance to oncolytic virus therapy
Abstract Background Oncolytic virus therapy (OVT) represents a promising frontier in cancer treatment. Despite its efficacy in clinical trials, variability in patient response, particularly resistance development, highlights the need for tailored therapeutic strategies. Methods The Inositol Hexakisp...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Journal of Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12967-025-06265-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|